Vendor profile Research · US · —

Skye Peptides

D
Composite 4.7 / 10

Last updated 2026-10-05. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
5.9
Fair
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
0.6
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
GHK-Cu
7.0B
8.8 2 — — — — view
Semaglutide
6.3C
7.9 9 — — — — view
Tirzepatide
6.2C
7.8 12 — — — — view
Retatrutide
5.8C
7.2 13 — — — — view
Ipamorelin
5.4C
6.8 8 — — — — view
CJC-1295
3.3E
2.9 7 — — — — view
Tesamorelin
3.1E
3.9 8 — — — — view
BPC-157
3.1E
3.9 17 — — — — view
TB-500
2.9E
3.7 3 — — — — view
Sermorelin
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Skye Peptides against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.